HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hudson, B. I. Articles by Grant, P. J. Search for Related Content PubMed PubMed Citation Articles by Hudson, B. I. Articles by Grant, P. J. Social Bookmarking                What's this?

Effects of Novel Polymorphisms in the RAGE Gene on Transcriptional Regulation and Their Association With Diabetic Retinopathy

Academic Unit of Molecular Vascular Medicine, University of Leeds, Leeds General Infirmary, Leeds, U.K.

Interactions between advanced glycation end products (AGEs) and the receptor for AGE (RAGE) are implicated in the vascular complications in diabetes. We have identified eight novel polymorphisms, of which the -1420 (GGT)n, -1393 G/T, -1390 G/T, and -1202 G/A were in the overlapping PBX2 3' untranslated region (UTR), and the -429 T/C (66.5% TT, 33.5% TC/CC), -407 to –345 deletion (99% I, 1% I/D, 0% D), -374 T/A (66.4% TT, 33.6% TA/AA), and +20 T/A were in the RAGE promoter. To evaluate the effects on transcriptional activity, we measured chloramphenicol acetyl transferase (CAT) reporter gene expression, driven by variants of the –738 to +49 RAGE gene fragment containing the four polymorphisms identified close to the transcriptional start site. The –429 C, -374 A, and 63-bp deletion alleles resulted in a mean increase of CAT expression of twofold (P < 0.0001), threefold (P < 0.001), and fourfold (P < 0.05), respectively, with the –374 T and A alleles yielding highly differential binding of nuclear protein extract from both monocyte- and hepatocyte-derived cell lines. The prevalence of the functional polymorphisms were investigated in subjects with type 2 diabetes (106 with and 109 without retinopathy), with the –429 C allele showing an increase in the retinopathy group (P < 0.05). These data suggest that the polymorphisms involved in differences in RAGE gene regulation may influence the pathogenesis of diabetic vascular complications.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. Kalousova, M. Jachymova, O. Mestek, M. Hodkova, M. Kazderova, V. Tesar, and T. Zima Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients Nephrol. Dial. Transplant., July 1, 2007; 22(7): 2020 - 2026. [Abstract] [Full Text] [PDF]

				J. Laki, I. Laki, K. Nemeth, R. Ujhelyi, O. Bede, E. Endreffy, K. Bolbas, K. Gyurkovits, E. Csiszer, E. Solyom, et al. The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis Int. Immunol., November 1, 2006; 18(11): 1585 - 1590. [Abstract] [Full Text] [PDF]

				R. Y.L. Zee, J. R. Romero, J. L. Gould, D. A. Ricupero, and P. M Ridker Polymorphisms in the Advanced Glycosylation End Product-Specific Receptor Gene and Risk of Incident Myocardial Infarction or Ischemic Stroke Stroke, July 1, 2006; 37(7): 1686 - 1690. [Abstract] [Full Text] [PDF]

				K. Kankova, A. Stejskalova, M. Hertlova, and V. Znojil Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1093 - 1102. [Abstract] [Full Text] [PDF]

				C. L. Lobo, R. C. Bernardes, J. P. Figueira, J. R. F. de Abreu, and J. G. Cunha-Vaz Three-Year Follow-up Study of Blood-Retinal Barrier and Retinal Thickness Alterations in Patients With Type 2 Diabetes Mellitus and Mild Nonproliferative Diabetic Retinopathy Arch Ophthalmol, February 1, 2004; 122(2): 211 - 217. [Abstract] [Full Text] [PDF]

				X. JiXiong, X. BiLin, Y. MingGong, and L. ShuQin -429T/C and -374T/A Polymorphisms of RAGE Gene Promoter Are Not Associated With Diabetic Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care, September 1, 2003; 26(9): 2696 - 2697. [Full Text] [PDF]

				K. Pettersson-Fernholm, C. Forsblom, B. I. Hudson, M. Perola, P. J. Grant, and P.-H. Groop The Functional -374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients Diabetes, March 1, 2003; 52(3): 891 - 894. [Abstract] [Full Text] [PDF]

				J. J. Rogus, J. H. Warram, and A. S. Krolewski Genetic Studies of Late Diabetic Complications: The Overlooked Importance of Diabetes Duration Before Complication Onset Diabetes, June 1, 2002; 51(6): 1655 - 1662. [Abstract] [Full Text] [PDF]

				B. I. Hudson, M. H. Stickland, P. J. Grant, and T. S. Futers Characterization of Allelic and Nucleotide Variation Between the RAGE Gene on Chromosome 6 and a Homologous Pseudogene Sequence to Its 5' Regulatory Region on Chromosome 3: Implications for Polymorphic Studies in Diabetes Diabetes, December 1, 2001; 50(12): 2646 - 2651. [Abstract] [Full Text] [PDF]

				B. I. Hudson, M. H. Stickland, T. S. Futers, and P. J. Grant Study of the -429 T/C and -374 T/A Receptor For Advanced Glycation End Products Promoter Polymorphisms in Diabetic and Nondiabetic Subjects With Macrovascular Disease Diabetes Care, November 1, 2001; 24(11): 2004 - 2004. [Full Text] [PDF]